Intent To Grant an Exclusive License of U.S. Government-Owned Patents, 29057 [2017-13408]

Download as PDF mstockstill on DSK30JT082PROD with NOTICES Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices smalltooth sawfish to develop conservation and protective measures, ensuring species recovery. Other listed species potentially encountered and incidentally collected include green, hawksbill, Kemp’s ridley, leatherback, and loggerhead sea turtles. Researchers may capture smalltooth sawfish in Florida waters, and then measure, weigh, tag, genetic tissue sample, draw blood, and photograph the animals prior to release. The researchers will also receive salvaged animals and parts taken at other locations within the target species’ range. The permit is valid through May 31, 2022. Permit No. 21155: The requested permit (82 FR 13801) authorizes the importation of 118 DNA samples from the Federal University of Rio Grande Do Sul in Brazil to the University of Michigan, Ecology and Evolutionary Biology Department in Ann Arbor, MI, for genetics research. The Atlantic spotted dolphins (Stenella frontalis) samples were collected between 1996 and 2016 via biopsy sampling of live animals or from stranded animals, in accordance with the laws of Brazil. The permit also authorizes the export of any remaining samples back to Brazil. The permit is valid for five months. Permit No. 21199: The requested permit (82 FR 18739) authorizes the BBC Natural History Unit to film killer whales (Orcinus orca), Dall’s porpoise (Phocoenoides dalli), and Pacific whitesided dolphins (Lagenorhynchus obliquidens). Filming may occur near Seward, Alaska over six days in May 2017 and in Juneau, AK over six days at the end of July 2017. Filming would occur from cameras on board a vessel or by helicopter. Hydrophones would be used to record vocalizations. Footage would be used for an Alaska Live television series to showcase the gathering of wildlife in Alaska that occurs around the salmon runs. The permit is valid through August 31, 2017. In compliance with the National Environmental Policy Act of 1969 (42 U.S.C. 4321 et seq.), a final determination has been made that the activities proposed are categorically excluded from the requirement to prepare an environmental assessment or environmental impact statement. As required by the ESA, as applicable, issuance of these permit was based on a finding that such permits: (1) Were applied for in good faith; (2) will not operate to the disadvantage of such endangered species; and (3) are consistent with the purposes and policies set forth in section 2 of the ESA. VerDate Sep<11>2014 18:33 Jun 26, 2017 Jkt 241001 Dated: June 22, 2017. Catherine Marzin, Acting Deputy Director, Office of Protected Resources, National Marine Fisheries Service. [FR Doc. 2017–13434 Filed 6–26–17; 8:45 am] BILLING CODE 3510–22–P DEPARTMENT OF DEFENSE Department of the Air Force U.S. Air Force Partially Exclusive Patent License Department of the Air Force, Air Force Research Laboratory Information Directorate, Rome, New York, Department of Defense. ACTION: Notice of intent to issue a partially exclusive patent license. AGENCY: The Department of the Air Force announces its intention to grant Mentis Technologies, having a place of business at 725 Daedalian Drive, Rome, New York 13440, a partially exclusive license in any right, title and interest the United States Air Force has in: In U.S. Patent No. 9,349,007 issued on May 24, 2016 and entitled ‘‘WEB MALWARE BLOCKING THROUGH PARALLEL RESOURCE RENDERING’’, having been filed on May 29, 2014 as U.S. Patent Application No. 14/290,175. FOR FURTHER INFORMATION CONTACT: An exclusive license for this patent will be granted unless a written objection is received within fifteen (15) days from the date of publication of this Notice. Written objections should be sent to: Air Force Research Laboratory, Office of the Staff Judge Advocate, AFRL/RIJ, 26 Electronic Parkway, Rome, New York 13441–4514. Telephone: (315) 330– 2087; Facsimile (315) 330–7583. SUMMARY: Authority: Pursuant to the provisions of part 404 of Title 37, Code of Federal Regulations, which implements Public Law 96–517, as amended. Henry Williams, Acting Air Force Federal Register Liaison Officer. [FR Doc. 2017–13402 Filed 6–26–17; 8:45 am] BILLING CODE 5001–10–P Department of the Army Intent To Grant an Exclusive License of U.S. Government-Owned Patents Department of the Army, DoD. Notice. AGENCY: ACTION: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), SUMMARY: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license to U.S. Patent 7,956,086, issued June 7, 2011, entitled, ‘‘Methods for the Formulation and Manufacture of Artesunic Acid for Injection’’ to Amivas, LLC, having its principal place of business at 8403 Colesville Road, Suite 630, Silver Spring, Maryland 20910. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: For licensing issues, Mr. Barry Datlof, Office of Research & Technology Applications, (301) 619–0033. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808, both at telefax (301) 619– 5034. Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES). SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2017–13408 Filed 6–26–17; 8:45 am] BILLING CODE 5001–03–P DEFENSE NUCLEAR FACILITIES SAFETY BOARD Sunshine Act Notice Defense Nuclear Facilities Safety Board. ACTION: Notice of closed meeting. AGENCY: Pursuant to the provisions of the Government in the Sunshine Act (5 U.S.C. 552b), and the Defense Nuclear Facilities Safety Board’s (Board) regulations implementing the Government in the Sunshine Act, notice is hereby given of the Board’s closed meeting described below. DATES: 10:00 a.m.–11:00 a.m., July 18, 2017. SUMMARY: Defense Nuclear Facilities Safety Board, 625 Indiana Avenue NW., Suite 700, Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Glenn Sklar, General Manager, Defense Nuclear Facilities Safety Board, 625 Indiana Avenue NW., Suite 700, Washington, DC 20004–2901, (800) 788– 4016. This is a toll-free number. SUPPLEMENTARY INFORMATION: The meeting will be closed to the public. No ADDRESSES: DEPARTMENT OF DEFENSE 29057 E:\FR\FM\27JNN1.SGM 27JNN1

Agencies

[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Page 29057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13408]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of U.S. Government-Owned 
Patents

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license to U.S. Patent 7,956,086, issued June 7, 
2011, entitled, ``Methods for the Formulation and Manufacture of 
Artesunic Acid for Injection'' to Amivas, LLC, having its principal 
place of business at 8403 Colesville Road, Suite 630, Silver Spring, 
Maryland 20910.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Mr. Barry 
Datlof, Office of Research & Technology Applications, (301) 619-0033. 
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-
7808, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this 
license can file written objections along with supporting evidence, if 
any, within 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2017-13408 Filed 6-26-17; 8:45 am]
 BILLING CODE 5001-03-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.